Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Neoplasms

Explore clinical trials studying Gastrointestinal Neoplasms. Study availability and eligibility vary by location and protocol.

9,263 public trials 2,060 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Neoplasms trial results

Completed

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

NCT02178722

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +76 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • US Davis Cancer Center Sacramento, California, United States
  • University Of Colorado Cancer Center Aurora, Colorado, United States
View all 24 locations
View Trial Details
Completed

Phase 1 Study of MGD007 in Relapsed/Refractory Metastatic Colorectal Carcinoma

NCT02248805

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Carcinoma, +10 more
Locations
  • Yale University, Yale Cancer Center New Haven, Connecticut, United States
  • H. Lee Moffitt Cancer Center & Research Institute, Inc Tampa, Florida, United States
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery

NCT02292758

Conditions
Colonic Diseases, Colorectal Adenocarcinoma, Colorectal Neoplasms, +13 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Saint Luke's Mountain States Tumor Institute Boise, Idaho, United States
  • Siouxland Regional Cancer Center Sioux City, Iowa, United States
  • Cancer Center of Kansas - Wichita Wichita, Kansas, United States
View all 13 locations
View Trial Details
Completed

Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.

NCT02947165

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +38 more
Locations
  • Sarah Cannon Research Institute SC Nashville, Tennessee, United States
  • Huntsman Cancer Institute SC Salt Lake City, Utah, United States
  • Novartis Investigative Site Salzburg, Austria
  • Novartis Investigative Site Toronto, Ontario, Canada
View Trial Details

Related conditions